STEVENSON, Md., April 04, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Omega Protein Corporation (NYSE:OME) (“Omega” or the “Company”) securities during the period between June 4, 2013 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 1, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Omega securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Omega’s subsidiary was potentially not in compliance with its probation terms, that the Company was not properly protecting whistleblower employees, and the Company was vulnerable to a U.S. Securities and Exchange Commission (“SEC”) investigation and potential civil and criminal liability.
According to the complaint, following a March 1, 2017 announcement that in December 2016 the Company received a subpoena from the SEC requesting information in connection with an investigation relating to the Company’s subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees, the value of Omega shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Omega securities purchased on or after June 4, 2013 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 



